Gene · 6368
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term intermittent hypoxia in mice induces inflammatory pathways implicated in sleep apnea and steatohepatitis in humans. | iScience | 2024 | 38303705 | PubTator, text mining | PubMed |
| HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation. | Pathogens | 2024 | 38276160 | PubTator, text mining | PubMed |
| Developing an early warning system for detecting sepsis in patients with trauma. | Int Wound J | 2024 | 38272793 | PubTator, text mining | PubMed |
| Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity. | Immun Inflamm Dis | 2024 | 38270321 | PubTator, text mining | PubMed |
| Researching New Drug Combinations with Senolytic Activity Using Senescent Human Lung Fibroblasts MRC-5 Cell Line. | Pharmaceuticals (Basel) | 2024 | 38256903 | PubTator, text mining | PubMed |
| Fibrous Remodeling in Eosinophilic Esophagitis: Clinical Facts and Pathophysiological Uncertainties. | Int J Mol Sci | 2024 | 38256003 | PubTator, text mining | PubMed |
| CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer. | Medicine (Baltimore) | 2024 | 38241595 | PubTator, text mining | PubMed |
| Targeting TIGIT for cancer immunotherapy: recent advances and future directions. | Biomark Res | 2024 | 38229100 | PubTator, text mining | PubMed |
| Immunomodulatory differences between mesenchymal stem cells from different oral tissues. | Heliyon | 2024 | 38192855 | PubTator, text mining | PubMed |
| Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases. | Oncoimmunology | 2024 | 38169917 | PubTator, text mining | PubMed |
| Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer. | Cell Commun Signal | 2024 | 38167013 | PubTator, text mining | PubMed |
| Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer. | Clin Cancer Res | 2024 | 37939140 | PubTator, text mining | PubMed |
| Suggested role for neutrophil extracellular trap formation in Ewing sarcoma immune microenvironment. | Cancer Sci | 2024 | 37915266 | PubTator, text mining | PubMed |
| Associations of inflammation-related proteome with demographic and clinical characteristics of people with HIV in South Africa. | Proteomics Clin Appl | 2024 | 37672793 | PubTator, text mining | PubMed |
| Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study. | Front Immunol | 2023 | 38288119 | PubTator, text mining | PubMed |
| Probiotic Lactobacillus plantarum GUANKE effectively alleviates allergic rhinitis symptoms by modulating functions of various cytokines and chemokines. | Front Nutr | 2023 | 38288067 | PubTator, text mining | PubMed |
| Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease. | Front Immunol | 2023 | 38259437 | PubTator, text mining | PubMed |
| Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation. | Front Immunol | 2023 | 38235129 | PubTator, text mining | PubMed |
| The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis. | Int J Mol Sci | 2023 | 38203309 | PubTator, text mining | PubMed |
| Extensive prediction of drug response in mutation-subtype-specific LUAD with machine learning approach. | Oncol Res | 2023 | 38186568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6368/papers?page=7